TrialCancer2015
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.
Jorge E Cortes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled ittrialcites it